List of Genetic Analysis/Screening Companies in United Kingdom - 22

Cambridge Nucleomics is a biotechnology company that specializes in fast and easy RNA measurement at scale with single-molecule accuracy.

Starting with a vision to truly take paternity testing to the general public, Complement Genomics has been bringing forward new DNA testing services since 2000. Working in areas as diverse as clinical trials and non-human DNA testing, the highly trusted company has considerable expertise in pharmacogenetics. Complement Genomics also provides COVID-19 testing for private clients and businesses. Operating from the Durham Genome Centre, Complement Genomics has developed different brands according to the market segment: - dadcheck®gold - DNA testing services for professionals, including solicitors, barristers, local authorities and social services - dadcheck®silver - a full range of DNA testing services for the general public, including paternity and other human relationships, for the determination of parentage, for immigration DNA tests or for DNA tests which are suitable for other legal purposes - Chxout - services designed to serve the non-human DNA testing market – for citizen scientists and professionals alike. Bat Species Identification | Bird Sexing | Bird Species Identification | Bird Parentage | DNA Barcoding of animals, plants and fungi - Geneblitz - designed to serve the CRO and pharmaceutical sector with genotyping and phenotyping for clinical trials - That DNA Company - an online value brand providing DNA testing services, primarily paternity tests, for the general public

Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide. Congenica’s Platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care. Our products and services are consolidated on one single scalable, automated analysis and diagnostic platform that encompasses inherited disease, somatic cancer, pharma insights and pathogen surveillance. Congenica was founded based on pioneering work at the Wellcome Trust Sanger Institute and the UK NHS. We are the exclusive clinical decision support partner for the NHS Genomic Medicine Service and have a global footprint supporting leading international laboratories, academic medical centres, hospitals and biopharmaceutical companies.

Cytocell is a biotechnology company that specializes in designing and manufacturing a variety of fluorescence in situ hybridisation (FISH) probes.

DNAe is commercializing its pioneering semiconductor sequencing technology for healthcare applications where rapid point-of-need diagnostics are of critical need, including infectious disease and cancer testing and monitoring. It is developing the LiDia-SEQ™ system, a user-friendly, direct-from-specimen platform that performs genomic analysis on a microchip, to provide comprehensive, actionable information to clinicians in a matter of hours, versus days. DNAe’s initial focus is on infectious disease diagnostics, starting with a groundbreaking test for bloodstream infections (BSI) and antimicrobial resistance (AMR), which uses whole blood specimens to directly detect and identify infections that lead to sepsis. This will provide clinicians with actionable information to help select the appropriate antibiotics to treat the disease. A pipeline of follow-on tests is in development for viruses and cancer testing and monitoring. DNAe has received “Breakthrough Device” designation from the US Food and Drug Administration (FDA) for its pioneering platform and first assay. Headquartered in London, UK, DNAe has expanded operations further in with a clinical diagnostic development and manufacturing site in San Diego, CA. We are always on the lookout for exceptional talent. For more details, visit www.dnae.com. Or get in touch, we would love to hear from you. Twitter: @dna_electronics Instagram: dna.electronics

DNA Worldwide is a specialist DNA, Hair Drug & Alcohol testing company providing a comprehensive range of home and legal DNA tests. DNA Worldwide concentrates on quality and customer service certified to ISO 9001:2008. It exceeds all UK and international requirements for testing through its ISO:17025 certified partner laboratory. All tests are dealt with discretely, efficiently and are subject to the highest levels of security with accuracy of 100%. A team of over 200 leading industry scientists is backed up by dedicated and supportive customer care, regularly dealing with paternity testing for family disputes, immigration testing as well as more complex testing of special specimens. The company also offers siblingship, Aunt/Uncle testing and Grandparent testing.

Evonetix is set to revolutionizede novogene synthesis to facilitate the fast-growing and exciting field of synthetic biology.The company's unique selling point is driven by high fidelity and parallelization of gene synthesis.Evonetix's technology is based upon a novel silicon array, manufactured with semiconductor microfabrication techniques and capable of independent control of 10,000 miniaturized reaction sites, allowing massive parallelism in the DNA synthesis process and therefore very high throughput.

We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalized estimates of risk for all the common diseases and cancers, well ahead of disease manifestation, allowing accurate and early interventions and tailored screening. Our proprietary algorithms and databases offer something no competitor can: the ability to accurately link minute variation across the entire genome to changes in thousands of biological measurements and disease outcomes, to generate population-level insights for healthcare systems, individual-level insights for clinicians about the risk of common diseases, and new understanding of disease processes. In August 2018, we announced a multi-year collaboration with Vertex to use human genetics and data science to advance discovery of precision medicines. We also has several pilot programmes in development within UK and US healthcare systems. Our team is a multi-disciplinary group focused on finding powerful and creative solutions for bringing subject-leading science to as wide an audience as possible, and, in doing so, offer the chance of transforming lives around the world. The workforce is highly qualified and consists of over 90 people, including genomic scientists, computational biologists, statisticians, software engineers, product developers, data scientists and commercial strategists. We are headquartered in Oxford, with offices in Cambridge (UK) and Boston (US).

At Lifebit, we're pushing forward the frontiers of health and knowledge by democratising access to omics data. We enable all researchers, whether novice or advanced, to run complex analyses and generate meaningful insights fast. Lifebit CloudOS is the world’s first federated genomics platform for unified and secure research over distributed big data - wherever data resides. From top tier pharmaceutical organisations to global research institutes to genetics companies and more, Lifebit CloudOS leads the way with our best-in-class UX/UI, seamless integration to open-source tools, marketplace of proprietary ones, powerful cohort browser, and advanced AI functionality. At Lifebit, we are open source pioneers, innovators redefining our industry. Our driving mission - to revolutionise bioinformatics and biomedical data analysis forever. We are growing fast and looking for more superstars to join our team.

Living DNA is a high definition DNA testing that challenges the concept of race and tackles ideas of separation through our 'One Family, One World'​ education programmes. With 75% of clients living overseas we do this globally. Presenting self-truth and letting science talk helps people change their lives. Putting ancestry into context allows people to celebrate not only how unique they are but also understand how we are all connected going back through history.

Omecu are the developers of a high performance genomics analysis platform providing secure access to large scale distributed datasets. Our team have spent over 10 years researching and developing in this area - building software solutions that allow researchers to quickly analyse large genomic datasets whilst ensure the security of the underlying data for the data holder. The company was formed in early 2021 to build on the research and development work from the university in this area.

As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, arrays and FISH reflects our commitment to improving the future of genetic clinical care. We offer partnership and collaboration to our customers at every stage of their work.

Pathios Therapeutics is a clinical-stage oncology and immunology company that targets the acid-sensing GPCR, GPR65. The company is focused on the development of first-in-class therapies for cancer.

RevoluGen is a privately held scientific research and development company commercialising molecular tools with a specific focus on rapidly extracting long and pure DNA fragments from cells. RevoluGen's Nucleic Acid Isolation and Purification (NAIP) products have broad application across short- and long-read DNA sequencing, including in population genomics, epidemiological mutation screening and antibiotic microbial resistance gene monitoring. Fire Monkey significantly improves sequencing results by extracting long-fragment DNA with a simultaneous size selection function built into the protocol that minimises the small-fragment DNA contamination. Used independently, the size selection protocol of Fire Flower can improve the molecular ratio of any extraction kit and is compatible with all sequencing technologies. The Company headquarters, R&D, manufacturing and direct customer sales and support are based in the UK. RevoluGen serves customers worldwide and has secured agreements with world-leading molecular biology tools companies including Merck KGaA (sales), Cytiva (manufacturing), Tecan (automation) and A4P (logistics). Watch our film https://vimeo.com/465291714 and animation https://lnkd.in/dHy3E3s

Sano combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams driving breakthroughs for patients.

Sense is transforming healthcare by redefining diagnostics. Founded in 2014, we strive to improve lives by bringing powerful tools for fast, accurate, and accessible diagnostics to all. We’re focused on creating a portfolio of unconstrained, instrument-free molecular diagnostic technologies. Our Veros™ platform introduces novel and proprietary rapid molecular amplification technology to detect a variety of deadly and costly diseases. We’re developing technologies that combine the power of laboratory tests with the simplicity and ease of use of products because we believe that if you can test anywhere, you can change everything.* *Professional use, patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

Sequential Skin is a Singapore-based healthcare organization that provides services such as genetics and microbiome research for the treatment of skin diseases.

Tagomics is a privately held company founded in 2020, with 2-10 employees. It is working to transform disease diagnosis through genetic, epigenetic, and fragmentomic features to identify disease-associated biomarkers and provide insights for disease profiling.

Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers. The company has raised significant investment to accelerate biotechnology innovations and has a team of 10 employees.

YouSeq is a biotechnology company founded in 2018 that specializes in molecular biology product development, particularly in multiplex Next-Generation Sequencing (NGS) and qPCR technologies. The company aims to simplify complex molecular diagnostics for researchers and clinicians, leveraging over 30 years of collective expertise among its founding team. YouSeq is committed to innovation and customer-centric solutions, with a focus on societal impact through charitable initiatives. The company develops user-friendly NGS and qPCR kits for detecting multiple diseases simultaneously, ensuring compatibility with various sequencing platforms. YouSeq also offers specialized multiplex panels and reagents optimized for high-throughput detection. During the COVID-19 pandemic, the company demonstrated its scalability by shipping over 5 million tests globally. YouSeq serves researchers, diagnostic laboratories, and healthcare providers, targeting global markets in infectious disease diagnostics and precision medicine. The company emphasizes a fulfilling work culture and pledges a portion of its profits to charitable causes, including educational support in Uganda.

Zetta provides large-scale genomic data management using distributed database technology and best practice security techniques to leverage genomicdata benefits while preserving data privacy.